This review reports the available evidence on the activation of the innate and adaptive
branches of the immune system and the related inflammatory processes in epileptic …

We have reviewed the literature of immune therapy in autoimmune encephalitis associated
with antibodies to cell surface antigens including N-methyl-D-aspartate receptor (NMDAR) …

Although seizures are frequent in all types of autoimmune encephalitis, the risk for chronic
epilepsy is dependent on the antigen: lower if located on the cell-surface, and higher if …

The field of autoimmune epilepsy has evolved substantially in the last few decades with
discovery of several neural autoantibodies and improved mechanistic understanding of …

ObjectiveEpilepsy is a chronic neurological disease characterised with seizures. The
aetiology of the most generalised epilepsies cannot be explicitly determined and the …

Most patients with N-methyl D-aspartate-receptor antibody encephalitis develop seizures but
the epileptogenicity of the antibodies has not been investigated in vivo. Wireless …

The clinical phenotype of leucine‐rich glioma‐inactivated protein 1 (LGI1) and contactin‐
associated proteinlike 2 (CASPR2) autoimmunity is well defined in adults. Data for children …

Leucine-rich glioma-inactivated protein 1 (LGI1) and contactin-associated protein-like 2
(CASPR2) neurological autoimmunity in adults has been associated with various clinical …

There is emerging interest in autoimmune epilepsy, which represents a small but potentially
treatable form of epilepsy. Most insights into autoimmune epilepsy derive from the recent …

Epilepsy affects~ 50 million people. In~ 30% of patients the etiology is unknown, and~ 30%
are unresponsive to anti-epileptic drugs. Intractable epilepsy often leads to multiple seizures …